Sean Reineke has served as CEO, President and Chairman of the Board of a variety of early-stage firms in the information technology and biotechnology fields over the last nine years, most recently as CEO and President of Innurvation, an early-stage medical device company focused on next generation capsule endoscopy where he is currently Chairman of the Board.
Sean previously served as Evogen’s (formerly Sceptor Industries) President and CEO. He helped to transform the company, originally focused on biodefense, into a molecular diagnostic and precision medicine biotechnology company through a series of company and technology acquisitions.
Previously, Sean held executive positions with Lockheed Martin at multiple locations, including Vice President positions running P&L business areas, strategic planning and business development, and he served two years at Lockheed Martin Headquarters as Vice President, Programs and Technology, for the $10B Systems Integration business area. Prior to that, Sean was an executive at IBM.
Sean has leadership experience in the entire range of commercial, civilian government, and DoD, serving domestic and international markets.
Numerous internal and external Executive Development programs including Disruptive Innovation at Harvard Business School
M.S., Computer Engineering, Syracuse University
B.S., Computer & Systems Engineering, Rensselaer Polytechnic Institute